Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

Abstract Background The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield...

Full description

Bibliographic Details
Main Authors: Mylène A. Carrascal, Catarina Talina, Paula Borralho, A. Gonçalo Mineiro, Ana Raquel Henriques, Cláudia Pen, Manuela Martins, Sofia Braga, Robert Sackstein, Paula A. Videira
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4410-x
_version_ 1811325543424983040
author Mylène A. Carrascal
Catarina Talina
Paula Borralho
A. Gonçalo Mineiro
Ana Raquel Henriques
Cláudia Pen
Manuela Martins
Sofia Braga
Robert Sackstein
Paula A. Videira
author_facet Mylène A. Carrascal
Catarina Talina
Paula Borralho
A. Gonçalo Mineiro
Ana Raquel Henriques
Cláudia Pen
Manuela Martins
Sofia Braga
Robert Sackstein
Paula A. Videira
author_sort Mylène A. Carrascal
collection DOAJ
description Abstract Background The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.
first_indexed 2024-04-13T14:35:03Z
format Article
id doaj.art-8f55e977b4ed44ed8949fa74815c40fc
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-13T14:35:03Z
publishDate 2018-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-8f55e977b4ed44ed8949fa74815c40fc2022-12-22T02:43:03ZengBMCBMC Cancer1471-24072018-05-0118111010.1186/s12885-018-4410-xStaining of E-selectin ligands on paraffin-embedded sections of tumor tissueMylène A. Carrascal0Catarina Talina1Paula Borralho2A. Gonçalo Mineiro3Ana Raquel Henriques4Cláudia Pen5Manuela Martins6Sofia Braga7Robert Sackstein8Paula A. Videira9UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de LisboaCEDOC, Chronic Diseases Research Center, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de LisboaCEDOC, Chronic Diseases Research Center, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de LisboaUCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de LisboaCEDOC, Chronic Diseases Research Center, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de LisboaCentro Hospitalar de Lisboa Central, EPE e Serviço de Anatomia PatológicaCentro Hospitalar de Lisboa Central, EPE e Serviço de Anatomia PatológicaHospital CUF DescobertasDepartments of Dermatology and Medicine, Brigham & Women’s Hospital, Harvard Medical SchoolUCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de LisboaAbstract Background The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.http://link.springer.com/article/10.1186/s12885-018-4410-xE-selectin ligandsSialyl-Lewis XSialyl-Lewis aCancer
spellingShingle Mylène A. Carrascal
Catarina Talina
Paula Borralho
A. Gonçalo Mineiro
Ana Raquel Henriques
Cláudia Pen
Manuela Martins
Sofia Braga
Robert Sackstein
Paula A. Videira
Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
BMC Cancer
E-selectin ligands
Sialyl-Lewis X
Sialyl-Lewis a
Cancer
title Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
title_full Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
title_fullStr Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
title_full_unstemmed Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
title_short Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
title_sort staining of e selectin ligands on paraffin embedded sections of tumor tissue
topic E-selectin ligands
Sialyl-Lewis X
Sialyl-Lewis a
Cancer
url http://link.springer.com/article/10.1186/s12885-018-4410-x
work_keys_str_mv AT myleneacarrascal stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT catarinatalina stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT paulaborralho stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT agoncalomineiro stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT anaraquelhenriques stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT claudiapen stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT manuelamartins stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT sofiabraga stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT robertsackstein stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue
AT paulaavideira stainingofeselectinligandsonparaffinembeddedsectionsoftumortissue